Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies

Abstract:
Scientists have made several advances in the design of a class of HIV vaccines that could offer broad protection against the virus, according to four new research papers published this week in Science, Science Translational Medicine, and Science Immunology. “The studies […] exemplify progress in the rational design of [germline-targeting] HIV-1 vaccines, and what is being learned will guide [germline-targeting] programs for inducing [broadly neutralizing antibodies] against other human pathogens,” Rogier Sanders and John Moore write in a related Perspective on the new articles.

Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies

Washington, DC | Posted on May 17th, 2024

As the HIV epidemic enters its fifth decade, scientists have poured time and resources into developing vaccine candidates for the virus. However, health authorities still lack a working, approved vaccine that induces broadly neutralizing antibodies, which can neutralize the most common circulating strains of HIV. One solution involves a process called germline targeting, where scientists use a series of proteins targeted by the immune system (immunogens) to shepherd and “prime” young B cells as they mature in sites called germinal centers, with the goal of coaxing the cells to produce broadly neutralizing antibodies against HIV. In the first paper in Science, Jon Steichen and colleagues tested the protective effects of a new germline-targeting strategy based on the N332-GT5 trimer, a component of the HIV viral envelope. Leveraging cryo-electron microscopy, the team showed that their approach successfully primed and boosted quantities of B cells that secret precursors to BG18 – an anti-HIV broadly neutralizing antibody – in a group of eight rhesus macaques. Taking a different delivery approach in the second Science study, Zhenfei Xie and colleagues demonstrated they could prime B cells with N332-GT5 via mRNA, which they delivered via lipid nanoparticles. When given to humanized mice, the mRNA delivered both the primary immunogen (N332-GT5) and two additional immunogens that further primed the target B cells. Together, these immunogens kickstarted the activation and expansion of B cells that secreted precursors to BG18, with Xie et al. hypothesizing that their strategy could reduce undesirable off-target binding. Meanwhile, in a study in Science Translational Medicine, Christopher Cottrell and colleagues designed a new nanoparticle immunogen as a boost to germline-targeting HIV vaccines. They first primed mice with an immunogen named eOD-Gt8 60mer, which was previously found to induce precursors to anti-HIV, VRC01-class broadly neutralizing antibodies in a phase 1 trial. After priming, Cottrell et al. then vaccinated mice with another immunogen named core-g28v2 60mer (in both protein and mRNA form) as a “first boost.” They found that this prime-boost approach elicited VRC01-class antibodies that were precursors to broadly neutralizing antibodies and neutralized HIV-like pseudoviruses in culture. Finally, in a study in Science Immunology, Xuesong Wang and colleagues showed that they could deliver eOD-Gt8 60mer as an initial priming immunogen via mRNA encapsulated in lipid nanoparticles. The researchers transferred several different humanized B cell lines into mice to mimic the competition between B cells that occurs during immunization. Their priming strategy coaxed B cells to diversify, participate in germinal centers, and acquire mutations and characteristics needed to secrete VRC01-class antibodies. In their related Perspective, Sanders and Moore add that the results provide a strong proof-of-concept for promising germline-targeting approaches, noting that the N332-GT5 trimer is now in a phase 1 trial.

####

For more information, please click here

Contacts:
Media Contact

Science Press Package Team
American Association for the Advancement of Science/AAAS

Expert Contacts

Andrew B. Ward
The Scripps Research Institute

Devin Sok
The Scripps Research Institute

Shane Crotty
The Scripps Research Institute/La Jolla Institute for Immunology/University of California, San Diego

Cell: +1-858-353-2139
William R. Schief
The Scripps Research Institute/Ragon Institute of MGH, MIT, and Harvard/Moderna, Inc.

Facundo D. Batista
The Ragon Institute of Mass General, MIT, and Harvard/Department of Biology, Massachusetts Institute of Technology

Perspective author: Rogier W. Sanders
Amsterdam UMC, University of Amsterdam/Amsterdam Institute for Immunology and Infectious Diseases/Weill Cornell Medicine

Perspective author: John P. Moore
Weill Cornell Medicine

Copyright © American Association for the Advancement of Science/AAAS

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

ARTICLE TITLE

Related News Press

News and information

New method in the fight against forever chemicals September 13th, 2024

Energy transmission in quantum field theory requires information September 13th, 2024

Breakthrough in proton barrier films using pore-free graphene oxide: Kumamoto University researchers achieve new milestone in advanced coating technologies September 13th, 2024

Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024

Possible Futures

Rice research could make weird AI images a thing of the past: New diffusion model approach solves the aspect ratio problem September 13th, 2024

Giving batteries a longer life with the Advanced Photon Source: New research uncovers a hydrogen-centered mechanism that triggers degradation in the lithium-ion batteries that power electric vehicles September 13th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

New discovery aims to improve the design of microelectronic devices September 13th, 2024

Nanomedicine

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

Discoveries

Energy transmission in quantum field theory requires information September 13th, 2024

Breakthrough in proton barrier films using pore-free graphene oxide: Kumamoto University researchers achieve new milestone in advanced coating technologies September 13th, 2024

Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024

New nanomaterial could transform how we visualise fingerprints: Innovative nanomaterials have the potential to revolutionise forensic science, particularly in the detection of latent (non-visible) fingermarks September 13th, 2024

Announcements

Giving batteries a longer life with the Advanced Photon Source: New research uncovers a hydrogen-centered mechanism that triggers degradation in the lithium-ion batteries that power electric vehicles September 13th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

New discovery aims to improve the design of microelectronic devices September 13th, 2024

New method in the fight against forever chemicals September 13th, 2024

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

Rice research could make weird AI images a thing of the past: New diffusion model approach solves the aspect ratio problem September 13th, 2024

Breakthrough in proton barrier films using pore-free graphene oxide: Kumamoto University researchers achieve new milestone in advanced coating technologies September 13th, 2024

Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024

New nanomaterial could transform how we visualise fingerprints: Innovative nanomaterials have the potential to revolutionise forensic science, particularly in the detection of latent (non-visible) fingermarks September 13th, 2024

Nanobiotechnology

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project